Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M43.7Revenue $M18.0Net Margin (%)-17.2Z-Score1.1
Enterprise Value $M37.1EPS $-0.2Operating Margin %-17.1F-Score2
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-17.2Higher ROA y-yN
Price/Book1.110-y EBITDA Growth Rate %-13.4Quick Ratio2.3Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %-25.2Current Ratio3.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-16.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-23.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.6ROI % (ttm)-16.6Gross Margin Increase y-yN

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 56.

No Entry found!

KOOL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy22,500$2.3-41.3 view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy100$2.44-44.67 view
ENGLE J MELVILLECEO 2009-09-25Buy25,000$2.28-40.79 view
MCENANY PATRICK JDirector 2009-05-19Buy6,250$2.32-41.81 view
ENGLE J MELVILLECEO 2009-05-12Buy25,000$2.2-38.64 view
MCENANY PATRICK JDirector 2009-05-08Buy6,250$2.12-36.32 view
HUCKEL HUBERT E MDDirector 2007-11-16Buy36,500$7.8-82.69 view
SEGAL DANIELVP Sales & Marketing 2007-03-01Buy750$12.56-89.25 view
HUCKEL HUBERT E MDDirector 2006-05-12Buy12,500$16.08-91.6 view
BARRY GEORGE JDirector 2006-05-12Buy250$16.28-91.71 view

Press Releases about KOOL :

    Quarterly/Annual Reports about KOOL:

    News about KOOL:

    Articles On GuruFocus.com
    comment on KOOL Dec 01 2011 
    comment on KOOL Aug 26 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
    THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
    THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 

    More From Other Websites
    CESCA Management Provides Regulatory Update on Its Proposed U.S. Pivotal Critical Limb Ischemia... Jul 08 2014
    Coverage initiated on Cesca Therapeutics by H.C. Wainwright Jun 26 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 16 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jun 13 2014
    Cesca Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants Jun 13 2014
    Cesca Therapeutics Announces Proposed Public Offering Jun 12 2014
    Cesca Therapeutics Announces Promising Longer-Term Safety and Efficacy Data on SurgWerks(R)-CLI From... Jun 10 2014
    Cesca Therapeutics to Present at LD Microcap Conference Jun 03 2014
    CESCA THERAPEUTICS INC. Financials May 23 2014
    Cesca Therapeutics to Present at the Third Annual Marcum Microcap Conference May 23 2014
    Cesca Therapeutics files $50M mixed securities shelf May 21 2014
    Cesca Therapeutics' (KOOL) CEO Matthew Plavan on Q3 2014 Results - Earnings Call Transcript May 15 2014
    Cesca Therapeutics reports Q3 EPS (7c) vs. (7c) in Q313 May 15 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 15 2014
    CESCA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report May 15 2014
    Cesca Therapeutics Reports Third Quarter Fiscal 2014 Results May 15 2014
    Cesca Therapeutics to Announce Third Quarter Fiscal 2014 Results on May 15, 2014 May 13 2014
    Cesca Therapeutics Announces the Appointment of Dr. Solomon Hamburg to Newly Formed Clinical and... May 12 2014
    CESCA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments... May 01 2014
    Cesca Executive Management Meets With Key Congressional Leaders on the Regenerative Medicine... Apr 30 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide